// company-profile

AbCellera Biologics Inc. Insider Trading

ABCL

Every SEC Form 4 insider trading filing for AbCellera Biologics Inc. (ABCL) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.

ExchangeNasdaqSectorPharmaceutical PreparationsInc.A1Filings52Insiders11
// api This AbCellera Biologics Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
curl "https://api.form4api.com/v1/transactions?ticker=ABCL" -H "X-Api-Key: YOUR_API_KEY"

// activity-summary

No insider transactions in the last 30 days.

// 90-day insight

Over the last 90 days, AbCellera Biologics Inc. insiders bought $143K across 8 transactions with no open-market sales.

  • Most active insider: Montalbano John S. with 2 transactions totaling $95K.
  • Largest single purchase: $95K by Montalbano John S. on May 14, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of AbCellera Biologics Inc. as of 2026-06-30

↓ decreasing
Total reported AUM
$147.4M
QoQ change
-67.0%
Reporting period
2026-06-30
#1
TD Waterhouse Canada Inc.
CIK 1999606
$72.6M
9.6M shares
#2
BlackRock, Inc.
CIK 2012383
$17.2M
2.2M shares
#3
Counterpoint Mutual Funds LLC
CIK 1698461
$7.6M
972K shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jul 1, 2026Seely LynnABCL
Award
152,207$0.00$0K
Jul 1, 2026Sandor VictorABCL
Award
152,207$0.00$0K
Jun 11, 2026Montalbano John S.ABCL
Award
111,701$0.00$0K
Jun 11, 2026Hayden Michael RABCL
Award
111,701$0.00$0K
Jun 11, 2026Quake StephenABCL
Award
111,701$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →